Lomond Therapeutics Holdings, Inc.
company.status.inactiveCIK 1900520fmd_02WT6ES704H45DRB87C2ESQJE3Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2021 to Mar 31, 2026, 18 periods
| Line item | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Research and development | – | 10 | 14 | 20 |
| Total operating expenses | – | 10 | 16 | 24 |
| Operating income | (0) | (10) | (16) | (24) |
| Interest expense | – | 0 | 0 | – |
| Interest and investment income | – | – | 0 | 1 |
| Other non-operating income (expense) | – | 0 | (1) | 1 |
| Income before taxes | – | – | 17 | 24 |
| Net income | (0) | (10) | (17) | (24) |